Extract from the Register of European Patents

EP About this file: EP1210939

EP1210939 - Pharmaceutical compositions comprising paracetamol and L-Cysteine or a precursor thereof [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.11.2006
Database last updated on 14.03.2026
Most recent event   Tooltip11.04.2008Lapse of the patent in a contracting state
New state(s): GR
published on 14.05.2008  [2008/20]
Applicant(s)For all designated states
Sinclair Pharmaceuticals Limited
Borough Road Godalming
Surrey GU7 2AB / GB
[2006/01]
Former [2005/48]For all designated states
Sinclair Pharmaceuticals Limited
Borough Road Godalming
Surrey GU7 2AB / GB
Former [2002/23]For all designated states
BTG INTERNATIONAL LIMITED
10 Fleet Place, Limeburner Lane
London EC4M 7SB / GB
Inventor(s)01 / Jones, Roger Spencer
Battle House
Brecon, Powys LD3 9RW / GB
 [2002/23]
Representative(s)Jappy, John William Graham
Gill Jennings & Every LLP The Broadgate Tower
20 Primrose Street
London EC2A 2ES / GB
[N/P]
Former [2005/41]Jappy, John William Graham
Gill Jennings & Every European Patent Attorneys Broadgate House 7 Eldon Street
London EC2M 7LH / GB
Former [2004/22]Peel, James Peter
Barker Brettell, 10-12 Priests Bridge
London SW15 5JE / GB
Former [2002/23]Dolan, Anthony Patrick
BTG International Ltd., 10 Fleet Place, Limeburner Lane
London EC4M 7SB / GB
Application number, filing date02002974.008.03.1994
[2002/23]
Priority number, dateGB1993000505812.03.1993         Original published format: GB 9305058
[2002/23]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1210939
Date:05.06.2002
Language:EN
[2002/23]
Type: A3 Search report 
No.:EP1210939
Date:07.08.2002
[2002/32]
Type: B1 Patent specification 
No.:EP1210939
Date:04.01.2006
Language:EN
[2006/01]
Search report(s)(Supplementary) European search report - dispatched on:EP24.06.2002
ClassificationIPC:A61K31/198, A61K9/20, A61K31/195, // (A61K31/198, 31:167)
[2002/32]
CPC:
A61K9/2059 (EP,US); A61K31/195 (EP,KR,US); A61K31/165 (KR);
A61K45/06 (EP,US); A61K9/2027 (EP,US); A61K9/2095 (EP,US);
A61P25/04 (EP); A61P29/00 (EP) (-)
C-Set:
A61K31/195, A61K2300/00 (US,EP);
A61K31/195, A61K31/165 (EP,US)
Former IPC [2002/23]A61K31/198, A61K9/20, // (A61K31/198, 31:167)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/23]
TitleGerman:Pharmazeutische Zusammensetzungen, die Paracetamol und L-Cystein oder eine Vorstufe davon enthalten[2002/23]
English:Pharmaceutical compositions comprising paracetamol and L-Cysteine or a precursor thereof[2002/23]
French:Compositions pharmaceutiques contenant du paracétamol et de la L-cystéine ou un précurseur de celle-ci[2002/23]
Examination procedure11.02.2002Examination requested  [2002/29]
17.01.2003Despatch of a communication from the examining division (Time limit: M04)
01.07.2003Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
14.08.2003Reply to a communication from the examining division
07.05.2004Despatch of a communication from the examining division (Time limit: M06)
27.10.2004Reply to a communication from the examining division
22.06.2005Communication of intention to grant the patent
12.10.2005Fee for grant paid
12.10.2005Fee for publishing/printing paid
Parent application(s)   TooltipEP94908449.5  / EP0689434
Opposition(s)05.10.2006No opposition filed within time limit [2006/50]
Request for further processing for:04.07.2003Request for further processing filed
04.07.2003Full payment received (date of receipt of payment)
Request granted
28.08.2003Decision despatched
Fees paidRenewal fee
11.02.2002Renewal fee patent year 03
11.02.2002Renewal fee patent year 04
11.02.2002Renewal fee patent year 05
11.02.2002Renewal fee patent year 06
11.02.2002Renewal fee patent year 07
11.02.2002Renewal fee patent year 08
20.02.2002Renewal fee patent year 09
11.03.2003Renewal fee patent year 10
15.03.2004Renewal fee patent year 11
23.02.2005Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipNL04.01.2006
IE08.03.2006
DK04.04.2006
SE04.04.2006
GR05.04.2006
PT05.06.2006
[2008/20]
Former [2007/45]NL04.01.2006
IE08.03.2006
DK04.04.2006
SE04.04.2006
PT05.06.2006
Former [2007/37]IT04.01.2006
NL04.01.2006
IE08.03.2006
DK04.04.2006
SE04.04.2006
PT05.06.2006
Former [2007/12]NL04.01.2006
IE08.03.2006
DK04.04.2006
SE04.04.2006
PT05.06.2006
Former [2006/52]NL04.01.2006
DK04.04.2006
SE04.04.2006
PT05.06.2006
Former [2006/48]NL04.01.2006
SE04.04.2006
PT05.06.2006
Former [2006/45]NL04.01.2006
SE04.04.2006
Documents cited:Search[DA] EP0100168  (STERWIN AG et al.) [DA] 1-18 * the whole document *
 [A] EP0426974  (HOECHST ROUSSEL PHARMA et al.) [A] 1-18 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.